Maggie Colton Cove
I'm a graduate student at UCSF focusing on translational cancer research. In my undergrad at University of Chicago I researched several small-molecule inhibitors against leukemia, investigating novel combination treatments for ALL and AML. I'm now interested in exploring other forms of cancer treatment, primarily immunotherapies. In the Okada lab, I'm investigating the application of engineered T cells against CNS tumors and working to improve the efficacy of these treatments. I'm a recipient of the T32 Translational Brain Tumor Research Training Grant and a Discovery Fellow. Outside of lab I enjoy playing music, trying new recipes and podcasting with Carry the One Radio.
Email: maggie.colton@ucsf.edu
2020, B.S. in Biological Sciences, University of Chicago, Chicago, IL
2022: T32 Translational Brain Tumor Research Training Grant
2022: Selected as a Discovery Fellow (Discovery Fellows Program in the Graduate Division at UCSF)
OTS167 blocks FLT3 translation and synergizes with FLT3 inhibitors in FLT3 mutant acute myeloid leukemia.
Eisfelder BJ, Saygin C, Wynne J, Colton MW, ... Roboz G, Alachkar H, Stock W.
Blood Cancer J. 2021 Mar 3;11(3):48. doi: 10.1038/s41408-021-00433-3. PMID: 33658483; PMCID: PMC7930094.